Analytical Framework to Navigate Microalgae-Based Product Development—Aligning Commercialization and Regulatory Pathways
Marine Drugs · 03.02.2026 · 24 (2) · 66
DOI: 10.3390/md24020066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 03.02.2026. Verfasst von Galey Tenzin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane 4072, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marine Bioproduct Cooperative Research Centre and Agri Futures, Marine Bioproduct Cooperative Research Centre and AgriFutures.
Abstract (Originalsprache)
After numerous false starts, the global microalgae industry is re-emerging, driven by its potential to address critical challenges in food and nutrition, sustainable energy, nutraceuticals, cosmetics and pharmaceuticals, and climate change mitigation. Although technical advances in microalgae production show value adding potential, progressing from innovation to product launch and competitiveness is complex. It requires an integrated understanding of technology readiness, regulatory compliance, financial necessities, and market competition. This study presents a novel analytical framework underpinning a data-enabled, evidence-based approach to navigating the innovation pathways to market and beyond. The framework integrates value-add opportunities, identifying key stages faced in pre-competitive (including Technology Readiness Level (TRL), R&D spend, and patent trends), and competitive market stages (including product launches, product claims, market size, market share, growth/maturity, international markets, distribution channels, sectoral profile, and competitive landscape), aligned with regulatory requirements. Although not without limitations, such as incomplete data for emerging products, as well as reliance on secondary sources for product stage determination and market size estimates which can influence the accuracy of TRL classification and market potential estimates. This integration of multiple analyses can help in identifying market opportunities and business competitiveness via product, business, and industry level analyses in the pre-competitive (pre-market launch) and competitive (on market) landscapes. Building on the team’s interdisciplinary experience of developing interactive dashboards for food and beverage industries, and microalga processes, this paper provides an overview of the framework, which was designed to guide businesses and researchers in an emerging microalgae industry through the complex landscape of product development along regulatory and commercial pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane 4072, Australia.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072, Australia.
- UQ Business School, The University of Queensland, Brisbane 4072, Australia.
ORCID-Profile: Kira Schipper, Edgar Brea
Förderung
- Marine Bioproduct Cooperative Research Centre and Agri Futures
- Marine Bioproduct Cooperative Research Centre and AgriFutures
Zitieren
APA
Tenzin, G., Schipper, K., Rathore, H., Shah, H., Brea, E., Hankamer, B., & Hine, D. (2026). Analytical Framework to Navigate Microalgae-Based Product Development—Aligning Commercialization and Regulatory Pathways. Marine Drugs, 24(2), 66. https://doi.org/10.3390/md24020066
Vancouver
Tenzin G, Schipper K, Rathore H, Shah H, Brea E, Hankamer B, et al. Analytical Framework to Navigate Microalgae-Based Product Development—Aligning Commercialization and Regulatory Pathways. Marine Drugs. 2026;24(2):66. doi:10.3390/md24020066
BibTeX
@article{Tenzin2026,
author = {Tenzin, Galey and Schipper, Kira and Rathore, Harshit and Shah, Hemil and Brea, Edgar and Hankamer, Ben and Hine, Damian},
title = {Analytical Framework to Navigate Microalgae-Based Product Development—Aligning Commercialization and Regulatory Pathways},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {2},
pages = {66},
doi = {10.3390/md24020066}
}
EUVIMED